C4 Therapeutics (CCCC) Other Working Capital Changes (2019 - 2026)
C4 Therapeutics' quarterly Other Working Capital Changes came in at -$122000.0 in Q1 2026, down 569.23% year-on-year from $26000.0 in Q1 2025, and up 98.59% quarter-over-quarter from -$8.7 million in Q4 2025.
C4 Therapeutics has reported Other Working Capital Changes for 8 years, with the latest figure at -$122000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 569.23% year-over-year to -$122000.0; the trailing twelve-month figure through Mar 2026 stood at -$19.0 million (down 33.61% YoY), and the FY2025 full-year result was -$18.8 million, down 535.21% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$122000.0, up from -$8.7 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $20.9 million in Q4 2022, with the low at -$21.1 million in Q2 2024.
- Average Other Working Capital Changes over 5 years is -$1.0 million, with a median of -$122000.0 recorded in 2026.
- Peak annual rise in Other Working Capital Changes reached 1140.14% in 2022, while the deepest fall reached 33163.93% in 2022.
- Tracing CCCC's Other Working Capital Changes over 5 years: stood at $20.9 million in 2022, then plunged by 86.86% to $2.7 million in 2023, then tumbled by 98.98% to $28000.0 in 2024, then slumped by 31103.57% to -$8.7 million in 2025, then surged by 98.59% to -$122000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$122000.0 (Q1 2026), -$8.7 million (Q4 2025), and -$7.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -122,000.00 |
| Mar 31, 2026 | -122,000.00 |
| Dec 31, 2025 | -8.68 Mn |
| Dec 31, 2025 | -8.68 Mn |
| Sep 30, 2025 | -7.32 Mn |
| Sep 30, 2025 | -7.32 Mn |
| Jun 30, 2025 | -2.86 Mn |
| Jun 30, 2025 | -2.86 Mn |
| Mar 31, 2025 | 26,000.00 |
| Mar 31, 2025 | 26,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Sep 30, 2024 | 6.86 Mn |
| Sep 30, 2024 | 6.86 Mn |
| Jun 30, 2024 | -21.12 Mn |
| Jun 30, 2024 | -21.12 Mn |
| Mar 31, 2024 | 18.56 Mn |
| Mar 31, 2024 | 18.56 Mn |
| Dec 31, 2023 | 2.74 Mn |
| Dec 31, 2023 | 2.74 Mn |
| Sep 30, 2023 | -10.57 Mn |
| Sep 30, 2023 | -10.57 Mn |
| Jun 30, 2023 | 7.84 Mn |
| Jun 30, 2023 | 7.84 Mn |
| Mar 31, 2023 | -2.73 Mn |
| Mar 31, 2023 | -2.73 Mn |
| Dec 31, 2022 | 20.89 Mn |
| Dec 31, 2022 | 20.89 Mn |
| Sep 30, 2022 | -20.29 Mn |
| Sep 30, 2022 | -20.29 Mn |
| Jun 30, 2022 | 4.90 Mn |
| Jun 30, 2022 | 4.90 Mn |
| Mar 31, 2022 | -5.88 Mn |
| Mar 31, 2022 | -5.88 Mn |
| Dec 31, 2021 | -2.01 Mn |
| Dec 31, 2021 | -2.01 Mn |
| Sep 30, 2021 | -61,000.00 |
| Sep 30, 2021 | -61,000.00 |
| Jun 30, 2021 | 1.14 Mn |
| Jun 30, 2021 | 1.14 Mn |
| Mar 31, 2021 | 40,000.00 |
| Mar 31, 2021 | 40,000.00 |
| Dec 31, 2020 | 3.91 Mn |
| Dec 31, 2020 | 3.91 Mn |
| Sep 30, 2020 | -222,000.00 |
| Sep 30, 2020 | -222,000.00 |
| Jun 30, 2020 | -217,000.00 |
| Jun 30, 2020 | -217,000.00 |
| Mar 31, 2020 | -212,000.00 |
| Mar 31, 2020 | -212,000.00 |
| Dec 31, 2019 | -336,000.00 |
| Dec 31, 2019 | -336,000.00 |